Skip to content

By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.

Peter Attia MDPeter Attia MD

#137 - Paul Offit, M.D.: An expert perspective on COVID-19 vaccines

Sign up to receive Peter's email newsletter: https://bit.ly/4c602k2 Paul Offit is a pediatrician specializing in infectious diseases and an expert in virology and vaccine development. He currently serves on the FDA committee overseeing and evaluating COVID-19 vaccines. In this episode, Paul discusses the strategies and major companies pursuing a vaccine against the SARS-CoV-2 virus. He gets into the nuances of the vaccine approval process and its implications for COVID-19 vaccine outlook. Paul also explains potential risks, reveals his own confidence level in safety, and gives insight into protection against reinfection with vaccination. Please note that this episode was recorded 11/05/2020, prior to the 11/09/2020 news release of the Pfizer vaccine update. We discuss: 00:00:00 - Intro 00:03:30 - How Paul’s experience as a child in a chronic care hospital as child informed his path in pediatrics and vaccine development 00:08:00 - Addressing the anti-vaccination sentiment and explaining the fraudulent origins of the anti-vaccination movement 00:17:00 - Lessons and insights from 26 years studying rotavirus and creating a successful rotavirus vaccine 00:27:15 - Developing a new vaccine: the different phases of clinical trials, overall timeline, and financial costs 00:32:30 - Operation Warp Speed: the expedited process of creating a coronavirus vaccine 00:35:00 - Various vaccine strategies—RNA, DNA, virus vector—and the challenges associated 00:41:15 - The Moderna and Pfizer mRNA vaccines: strategy, timeline, and Emergency Use Authorization 00:48:30 - Paul’s confidence level in the safety of the first coronavirus vaccines 00:52:15 - The risks associated with different types of vaccines, and updates on the Johnson & Johnson and Astrazeneca coronavirus vaccines 00:55:45 - What we know about the coronavirus vaccines approved in Russia and China 00:57:15 - The latest on the Merck coronavirus vaccine 00:57:45 - The recombinant/purified protein vaccine approach for coronavirus—big players, risks, and the best vaccine for the elderly 01:02:00 - Attenuated and inactivated vaccine strategies for coronavirus 01:02:30 - The genetic drift of SARS-CoV-2: Impacts for protection and vaccine development 01:06:45 - Paul’s take on the hypothesis that a previous coronavirus infection offers protection against the novel COVID-19 01:19:15 - Addressing the concern that antibodies fade over time 01:13:00 - Blood type and protective against coronavirus 01:13:15 - Distribution: the challenge of prioritizing the limited doses of vaccines after approval 01:16:15 - Paul’s perspective on COVID-19 vaccine safety 01:21:45 - Considerations regarding vaccinating children for coronavirus and the role of a fever immune response 01:29 :45 - Why vaccine development can be challenging and risks of current COVID-19 strategies Show notes page: https://peterattiamd.com/pauloffit/ About: The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 30 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more. Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life). Learn more: https://peterattiamd.com/ Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/ Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/ Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Play: http://bit.ly/TheDriveGooglePlay

Peter AttiahostPaul Offitguest
Nov 16, 20201h 36mWatch on YouTube ↗

Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.

Episode Details

EPISODE INFO

Released
November 16, 2020
Duration
1h 36m
Channel
Peter Attia MD
Watch on YouTube
▶ Open ↗

EPISODE DESCRIPTION

Sign up to receive Peter's email newsletter: https://bit.ly/4c602k2 Paul Offit is a pediatrician specializing in infectious diseases and an expert in virology and vaccine development. He currently serves on the FDA committee overseeing and evaluating COVID-19 vaccines. In this episode, Paul discusses the strategies and major companies pursuing a vaccine against the SARS-CoV-2 virus. He gets into the nuances of the vaccine approval process and its implications for COVID-19 vaccine outlook. Paul also explains potential risks, reveals his own confidence level in safety, and gives insight into protection against reinfection with vaccination. Please note that this episode was recorded 11/05/2020, prior to the 11/09/2020 news release of the Pfizer vaccine update. We discuss: 00:00:00 - Intro 00:03:30 - How Paul’s experience as a child in a chronic care hospital as child informed his path in pediatrics and vaccine development 00:08:00 - Addressing the anti-vaccination sentiment and explaining the fraudulent origins of the anti-vaccination movement 00:17:00 - Lessons and insights from 26 years studying rotavirus and creating a successful rotavirus vaccine 00:27:15 - Developing a new vaccine: the different phases of clinical trials, overall timeline, and financial costs 00:32:30 - Operation Warp Speed: the expedited process of creating a coronavirus vaccine 00:35:00 - Various vaccine strategies—RNA, DNA, virus vector—and the challenges associated 00:41:15 - The Moderna and Pfizer mRNA vaccines: strategy, timeline, and Emergency Use Authorization 00:48:30 - Paul’s confidence level in the safety of the first coronavirus vaccines 00:52:15 - The risks associated with different types of vaccines, and updates on the Johnson & Johnson and Astrazeneca coronavirus vaccines 00:55:45 - What we know about the coronavirus vaccines approved in Russia and China 00:57:15 - The latest on the Merck coronavirus vaccine 00:57:45 - The recombinant/purified protein vaccine approach for coronavirus—big players, risks, and the best vaccine for the elderly 01:02:00 - Attenuated and inactivated vaccine strategies for coronavirus 01:02:30 - The genetic drift of SARS-CoV-2: Impacts for protection and vaccine development 01:06:45 - Paul’s take on the hypothesis that a previous coronavirus infection offers protection against the novel COVID-19 01:19:15 - Addressing the concern that antibodies fade over time 01:13:00 - Blood type and protective against coronavirus 01:13:15 - Distribution: the challenge of prioritizing the limited doses of vaccines after approval 01:16:15 - Paul’s perspective on COVID-19 vaccine safety 01:21:45 - Considerations regarding vaccinating children for coronavirus and the role of a fever immune response 01:29 :45 - Why vaccine development can be challenging and risks of current COVID-19 strategies Show notes page: https://peterattiamd.com/pauloffit/ About: The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 30 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more. Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life). Learn more: https://peterattiamd.com/ Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/ Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/ Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Play: http://bit.ly/TheDriveGooglePlay

SPEAKERS

  • Peter Attia

    host

    Physician and host of The Drive podcast, focused on health and longevity.

  • Paul Offit

    guest

    Pediatrician and vaccinologist at Children’s Hospital of Philadelphia, known for work on the rotavirus vaccine RotaTeq and vaccine safety advocacy.

EPISODE SUMMARY

In this episode of Peter Attia MD, featuring Peter Attia and Paul Offit, #137 - Paul Offit, M.D.: An expert perspective on COVID-19 vaccines explores paul Offit Explains COVID-19 Vaccine Strategies, Risks, Safety Data, and Rollout Challenges Paul Offit links his childhood stay in a chronic care hospital during the polio era to his career in pediatrics, vaccine development, and child advocacy, and calls Andrew Wakefield a fraud whose discredited MMR-autism claim ended up marginalizing anti-vaccine voices.

RELATED EPISODES

409 ‒ Inside modern drug development: the science, economics, and regulatory hurdles

409 ‒ Inside modern drug development: the science, economics, and regulatory hurdles

#117 – Stanley Perlman, M.D., Ph.D.: Insights from a coronavirus expert on COVID-19

#117 – Stanley Perlman, M.D., Ph.D.: Insights from a coronavirus expert on COVID-19

#150-Senator Bill Frist, MD: A modern Renaissance man's journey through science, politics & business

#150-Senator Bill Frist, MD: A modern Renaissance man's journey through science, politics & business

#130 - Carol Tavris, Ph.D. & Elliot Aronson, Ph.D.: Recognizing and overcoming cognitive dissonance

#130 - Carol Tavris, Ph.D. & Elliot Aronson, Ph.D.: Recognizing and overcoming cognitive dissonance

#96–David Epstein: How range of experience leads to better performance in a highly specialized world

#96–David Epstein: How range of experience leads to better performance in a highly specialized world

#125 - John Arnold: The most prolific philanthropist you may not have heard of

#125 - John Arnold: The most prolific philanthropist you may not have heard of

Get more out of YouTube videos.

Read along on your phone, search it beside the video, or ask your favorite AI app what was said.